Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Apply
Rezpegaldesleukin
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step